SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001654954-19-008578
Filing Date
2019-07-29
Accepted
2019-07-29 14:27:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberATRA-201913g.htm SC 13G 62618
2 JOINT FILING AGREEMENT ATRA13g2019ex1.htm EX-1 4964
  Complete submission text file 0001654954-19-008578.txt   69246
Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 19980604
SIC: 2836 Biological Products, (No Diagnostic Substances)